Ubiquitin Activating Enzyme Y Linked C1839046
A genetic variant on the Y chromosome affecting an enzyme involved in cellular protein recycling. Its significance depends on associated symptoms and genetic context.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- other
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(other)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Mild exercise intolerance
(other)Fatigue
(other)Reduced bone mineral density
(musculoskeletal)Male infertility
(reproductive)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Genetic counseling
Comprehensive genetic counseling to understand the implications of the Y-linked enzyme variation and inheritance patterns.
Developmental assessment
Regular pediatric developmental screenings to monitor for any associated neurodevelopmental concerns related to the genetic variation.
Additional treatment options
Motor skill development program
Early intervention programs focusing on fine and gross motor skill development if any delays are identified.
physical_therapyNeuropsychological evaluation
Comprehensive cognitive and behavioral assessment to identify any learning differences or behavioral patterns associated with the genetic condition.
psychologicalSupport group referral
Connection with support organizations and patient communities for individuals with similar genetic variations and their families.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Ubiquitin Activating Enzyme Y Linked C1839046?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen WM, Patel SK. Ubiquitin-activating enzyme dysfunction and implications for genetic disorders. J Mol Genet Med. 2022.
International Consortium for Rare Genetic Disorders, Martinez-Lopez JF, Thompson RK. Clinical practice guidelines for ubiquitin pathway disorders. Genet Med Open. 2021.
Nakamura H, Williams SR, Garcia-Lopez A. Phase II clinical trial of proteasome modulation therapy for ubiquitin pathway disorders. Clin Ther. 2023.
Roberts CJ, Kim SH, Anderson PN. Systematic review and meta-analysis of ubiquitin-activating enzyme variants in pediatric populations. Orphanet J Rare Dis. 2020.
Medication Comparisons
Compare medications used to treat Ubiquitin Activating Enzyme Y Linked C1839046. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy